SciBase & Castle Biosciences expand collaboration and license agreement and enter into loan agreement of SEK 20 million: Stockholm, Sweden Saturday, November 8, 2025, 18:00 Hrs [I ...

Our Bureau, Mumbai Saturday, November 8, 2025, 17:15 Hrs [IST] ...

Intralink to drive Dyadic Applied BioSolutions’ expansion into Japan and Korea: Oxford, UK Saturday, November 8, 2025, 17:00 Hrs [IST] International business development consult ...

ClearPoint Neuro to acquire IRRAS Holdings to expand its drug delivery portfolio: Solana Beach, California Saturday, November 8, 2025, 16:00 Hrs [IST] ClearPoint Neuro Inc, a glob ...

The Infection Innovation Consortium: iiCON has marked its fifth year of operations with the launch of a new report highlighting its significant impact over the last 12 months. The consortium, which is ...

Ono Pharma, Bristol-Myers & Kyowa Hakko Kirin enter pact to condutct phase 1 combo study with Opdivo & mogamulizumab in advanced solid tumors: Tokyo Friday, December 12, 2014, 11: ...

Ardelyx grants exclusive rights to develop & commercialize tenapanor in China to Fosun Pharma: Fremont, California Tuesday, December 12, 2017, 11:00 Hrs [IST] Ardelyx, Inc. has en ...

Under the terms of the Agreement, Adimab will use its proprietary platform to generate bispecific molecules against multiple targets. Sanofi will have the right to develop and commercialise all ...

UK MHRA approves Serum Life Sciences’ Siiltibcy as a diagnostic aid for Mycobacterium tuberculosis infection, including disease: United Kingdom Saturday, November 8, 2025, 14:00 ...

Lupin Bioresearch Centre receives zero observations from US FDA after successful inspection and assessment: Our Bureau, Mumbai Saturday, November 8, 2025, 13:20 Hrs [IST] Global p ...

ORIC Pharmaceuticals announces scientific details of discovery and development of enozertinib: South San Francisco Saturday, November 8, 2025, 13:00 Hrs [IST] ORIC Pharmaceuticals ...

Alvotech and Advanz Pharma receive UK MHRA marketing approval for Gobivaz: Reykjavik, Iceland Saturday, November 8, 2025, 12:00 Hrs [IST] Alvotech, a global biotech company specia ...